---
document_datetime: 2023-09-21 18:28:55
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zontivity-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: zontivity-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.1677683
conversion_datetime: 2025-12-20 13:54:40.515516
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zontivity

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                   | Opinion/ Notification 1 issued on Commissio n Decision Issued 2 / amended on 16/08/2016 product no   | Product Information affected 3   | Summary                                                       |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------|----------------------------------|---------------------------------------------------------------|
| IB/0009              | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation Medicinal | n/a                                                                                                  |                                  |                                                               |
| II/0005              | Extension of Indication to include                                                                                                                      | 23/06/2016 29/07/2016                                                                                | SmPC,                            | Refer to the Scientific Discussion Zontivity- H-C- 2814-II-05 |

<!-- image -->

Medicinal product no longer authorised

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet).

The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                     | treatment of patients with symptomatic Peripheral Arterial Disease (PAD) and as a consequence, sections 4.1, 4.2, 4.4, 4.8 and 5.1 of the SmPC are updated. The Package Leaflet is updated accordingly. In addition, the Marketing authorisation holder (MAH) took the opportunity to update the contact details of local representative in Luxembourg in the Package Leaflet. Furthermore, the PI is brought in line with the QRD template version 9.1. Moreover, revised RMP version 2.4 has been agreed. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one product   | Annex II and PL no longer authorised   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|
| PSUSA/10357 /201507 | Periodic Safety Update EU Single assessment - VORAPAXAR 11/02/2016 Medicinal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | n/a                                    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           |                                                                                                                                                                                                                                                                                                                                                   | longer                     |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|
| N/0006    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                  | 22/09/2015 PL no           |
| IA/0004   | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                     | 16/09/2015 SmPC PL product |
| IA/0003/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of Medicinal | 08/05/2015 n/a             |

<div style=\"page-break-after: always\"></div>

|         | AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place   |            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
| IB/0001 | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                      | 26/03/2015 |

<!-- image -->